XML 45 R45.htm IDEA: XBRL DOCUMENT v2.4.0.6
BUSINESS COMBINATIONS (Details 6)
1 Months Ended 3 Months Ended 3 Months Ended 3 Months Ended 3 Months Ended 3 Months Ended
Mar. 31, 2012
USD ($)
Dec. 31, 2011
USD ($)
Sep. 30, 2011
Sanitas
USD ($)
Sep. 30, 2011
Sanitas
EUR (€)
Aug. 31, 2011
Sanitas
USD ($)
Jul. 31, 2011
Sanitas
Mar. 31, 2012
Sanitas
USD ($)
country
product
Y
Sep. 22, 2011
Sanitas
Sep. 15, 2011
Sanitas
Aug. 19, 2011
Sanitas
USD ($)
Aug. 18, 2011
Sanitas
USD ($)
Mar. 31, 2012
Sanitas
Product brands
Y
Aug. 19, 2011
Sanitas
Product brands
USD ($)
Mar. 31, 2012
Sanitas
Product rights
Y
Aug. 19, 2011
Sanitas
Product rights
USD ($)
Mar. 31, 2012
Sanitas
Corporate brands
Y
Aug. 19, 2011
Sanitas
Corporate brands
USD ($)
Mar. 31, 2012
Sanitas
Partner relationships
Y
Aug. 19, 2011
Sanitas
Partner relationships
USD ($)
Business Combinations                                      
Additional outstanding common shares acquired, percentage     6.40% 6.40% 87.20% 4.80%                          
Additional cash consideration paid     $ 27,400,000   $ 392,300,000                            
Additional outstanding common shares acquired     1,968,631 1,968,631   1,502,432                          
Outstanding common shares acquired, percentage                 98.40% 92.00%                  
Outstanding common shares acquired                 30,593,656 28,625,025                  
Noncontrolling interest, percent               1.60%   8.00% 4.80%                
Noncontrolling interest, fair value                   34,800,000 21,100,000                
Purchase price per share (in euros per share)       € 10.06                              
Noncontrolling interest, number of shares               512,264                      
Amount due shareholders of acquiree 543,310,000 527,583,000         2,400,000                        
Number of products in product portfolio             390                        
Number of countries of operation             9                        
Assets acquired and liabilities assumed                                      
Cash and cash equivalents                   5,607,000                  
Accounts receivable                   25,645,000                  
Inventories                   22,010,000                  
Other current assets                   3,166,000                  
Property, plant and equipment                   83,288,000                  
Identifiable intangible assets, excluding acquired IPR&D                   247,127,000     164,823,000   43,027,000   25,227,000   14,050,000
Acquired IPR&D 531,372,000 531,352,000               747,000                  
Other non-current assets                   2,662,000                  
Current liabilities                   (30,428,000)                  
Long-term debt, including current portion                   (67,134,000)                  
Deferred income taxes, net                   (43,269,000)                  
Other non-current liabilities                   (6,049,000)                  
Total identifiable net assets                   243,372,000                  
Goodwill                   204,791,000                  
Total fair value of consideration transferred                   448,163,000                  
Fair value of accounts receivable acquired                   25,600,000                  
Gross contractual amount of trade accounts receivable acquired                   27,800,000                  
Expected uncollectible of trade accounts receivable acquired                   $ 2,200,000                  
Estimated weighted-average useful life (in years)             8         7   7   15   7